Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 148 million vaccinations for PV in the adult population for the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there are seven leading marketed vaccines, with Merck & Co and Pfizer being key players in ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
... global viral vector and plasmid DNA manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2% during the forecast period of 2023 to ... Read More
-
Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Phase (Discovery Phase, Preclinical Phase, Clinical Phase), By Indication, By Sponsor Type, By Region, And Segment Forecasts, 2023 - 2030
... Ophthalmic Clinical Trials Market Growth & Trends The global ophthalmic clinical trials market size is expected to reach USD 2.5 billion by 2030 at a CAGR of 6.6% over the forecast period, according to a ... Read More
-
IDC Perspective: Why Is 5G High on Pharma's Radar?
... the roadblocks lie and provides guidance to technology buyers."As 5G technology becomes increasingly pervasive, as patients go remote, and as the adoption of decentralized clinical trials continues to grow, the life science industry will increasingly ... Read More
-
Viral Vector Production Market By Viral Vector Type (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors), By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The viral vector production market was valued for $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, exhibiting a CAGR of 18.8% from 2023 to ... Read More
-
Medical Terminology Software Market By Application (Quality Reporting, Reimbursement, Data Aggregation, Clinical Trials, Others), By End User (Healthcare Providers, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... was valued at $0.9 billion in 2022, and is projected to reach $2.6 billion by 2032, growing at a CAGR of 10.9% from 2023 to 2032.Medical terminology software is a specialized software that provides definitions, ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 300 million prevalent cases of GERD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The marketed drugs space for GERD comprises both novel class of potassium-competitive acid blockers (P-CABs) and ... Read More
-
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... in GlobalData’s epidemiology fact sheet, GlobalData epidemiologists estimated a total of 66,674 incident cases of mpox in 2022. Tecovirimat (Tpoxx) is the only approved medication for the treatment of severe complications of mpox that is ... Read More
-
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Vertigo Clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes ... Read More
-
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Renal Cell Carcinoma Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of narcolepsy in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. The majority of marketed drugs for the treatment of narcolepsy are transport inhibitors and receptor agonists. The narcolepsy pipeline consists ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report provides top line data ... Read More
-
Hyperglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hyperglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Report includes ... Read More
-
Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Diabetic Macular Edema Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Multiple Myeloma (Kahler Disease) Clinical trials scenario. This report provides top line data ... Read More
-
Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia. Report includes ... Read More
-
Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Muscle Invasive Bladder Cancer Clinical trials scenario. This report provides top line ... Read More
-
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 344 million prevalent cases of CLBP in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Chronic pain continues to be a significant global burden despite the availability of a variety of ... Read More
-
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
... UK, Japan, China) and provides an Excel-based forecast model for the Alzheimer's disease market through 2030. Alzheimer's Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. ... Read More
-
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Rhabdomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Rhabdomyosarcoma. Report includes ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data ... Read More
-
Clinical Trials - Impact of COVID-19 and Long COVID
... for these analyses were extracted from GlobalData’s Clinical Trials Database. The data was captured in the database as of April 12, 2023. The data was analyzed and segmented by COVID-19 trials, COVID-19 trials for vaccines ... Read More
-
Global Clinical Trials Market - 2023-2030
... The clinical trials market is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030). Clinical trials are a methodology of clinical investigation that is overseen by a designated protocol that is carefully ... Read More
-
AI-based Clinical Trial Solution Providers Market Report 2023-2033
... understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Number of Clinical ... Read More
-
Vaccine Contract Manufacturing Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Global Demand, Product Innovation and Cost Effectiveness ... Read More
Research Assistance
